Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP732447.RAbo3e1jxd0qlYYxKlwWEJrIhRaSt0TajJ_LCn88G2NME130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP732447.RAbo3e1jxd0qlYYxKlwWEJrIhRaSt0TajJ_LCn88G2NME130_assertion type Assertion NP732447.RAbo3e1jxd0qlYYxKlwWEJrIhRaSt0TajJ_LCn88G2NME130_head.
- NP732447.RAbo3e1jxd0qlYYxKlwWEJrIhRaSt0TajJ_LCn88G2NME130_assertion description "[This switch from a tumor suppressor in premalignant stages of tumorigenesis to a tumor promoter in later stages of the disease poses great challenges in TGFbeta-targeted cancer therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP732447.RAbo3e1jxd0qlYYxKlwWEJrIhRaSt0TajJ_LCn88G2NME130_provenance.
- NP732447.RAbo3e1jxd0qlYYxKlwWEJrIhRaSt0TajJ_LCn88G2NME130_assertion evidence source_evidence_literature NP732447.RAbo3e1jxd0qlYYxKlwWEJrIhRaSt0TajJ_LCn88G2NME130_provenance.
- NP732447.RAbo3e1jxd0qlYYxKlwWEJrIhRaSt0TajJ_LCn88G2NME130_assertion SIO_000772 20437081 NP732447.RAbo3e1jxd0qlYYxKlwWEJrIhRaSt0TajJ_LCn88G2NME130_provenance.
- NP732447.RAbo3e1jxd0qlYYxKlwWEJrIhRaSt0TajJ_LCn88G2NME130_assertion wasDerivedFrom befree-20150227 NP732447.RAbo3e1jxd0qlYYxKlwWEJrIhRaSt0TajJ_LCn88G2NME130_provenance.
- NP732447.RAbo3e1jxd0qlYYxKlwWEJrIhRaSt0TajJ_LCn88G2NME130_assertion wasGeneratedBy ECO_0000203 NP732447.RAbo3e1jxd0qlYYxKlwWEJrIhRaSt0TajJ_LCn88G2NME130_provenance.